Innoviva INVA
NASDAQ INVA
$21.33 -0.02 (-0.09%)
As of: Sep 4, 2026 · 3:59 PM EDT

Innoviva (INVA) Raw Materials (2012 - 2026)

Innoviva's (INVA) quarterly Raw Materials came in at $17.5 million in Q1 2026, up 64.44% YoY from $10.6 million in Q1 2025, and up 6.93% on a QoQ basis from $16.3 million in Q4 2025.

Analysis

Innoviva (INVA) Raw Materials (2012 - 2026) Analysis & Trends

Innoviva (INVA) has 8 years of Raw Materials data on file, last reported at $17.5 million in Q1 2026.

  • Quarterly Raw Materials rose 64.44% year-over-year to $17.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.5 million (up 64.44% YoY) and the FY2025 annual result came in at $16.3 million, up 46.95% from the prior year.
  • Raw Materials improved to $17.5 million in Q1 2026, from $16.3 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $17.5 million in Q1 2026 to a low of $5.8 million in Q3 2022.
  • A 5-year average of $10.4 million and a median of $9.5 million in 2024 frame the typical range for Raw Materials.
  • Annual changes were most pronounced in 2023 — Raw Materials surged 95.54% — and 2024, when it slipped 1.28%.
  • Tracing INVA's Raw Materials over 5 years: stood at $5.8 million in 2022, then surged by 95.54% to $11.3 million in 2023, then slipped by 1.28% to $11.1 million in 2024, then soared by 46.95% to $16.3 million in 2025, then climbed by 6.93% to $17.5 million in 2026.
  • The last three Raw Materials figures came in at $17.5 million (Q1 2026), $16.3 million (Q4 2025), and $14.4 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Innoviva 1.56 Bn 984.81 Mn 90.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.72 Mn
Mar 31, 2026 17.46 Mn
Dec 31, 2025 16.33 Mn
Sep 30, 2025 14.37 Mn
Jun 30, 2025 10.55 Mn
Mar 31, 2025 10.62 Mn
Dec 31, 2024 11.11 Mn
Sep 30, 2024 9.53 Mn
Jun 30, 2024 9.53 Mn
Mar 31, 2024 9.53 Mn
Dec 31, 2023 11.26 Mn
Sep 30, 2023 8.86 Mn
Jun 30, 2023 8.86 Mn
Mar 31, 2023 5.76 Mn
Dec 31, 2022 5.76 Mn
Sep 30, 2022 5.76 Mn
Mar 31, 2014 4.00 Mn
Dec 31, 2013 5.14 Mn
Sep 30, 2013 4.08 Mn
Jun 30, 2013 3.53 Mn